Floatz logo

Certepetide

Appendix Cancer

University of California, San Diegoprotein_peptidePhase 1Active
CC
41/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
81/ 100

Competitive context

21 Active assets in the Appendix Cancer cohort.

Asset / SponsorPhaseRating
CIS-DIAMMINEDICHLOROPLATINUM II
National Cancer Institute (NCI)
Phase 2BB
MITOMYCIN C
National Cancer Institute (NCI)
Phase 2B
Sodium Thiosulfate
National Cancer Institute (NCI)
Phase 2B
Nilotinib
National Cancer Institute (NCI)
Phase 2B
Floxuridine
Memorial Sloan Kettering Cancer Center
Phase 2CCC

View all 26 →

Same molecule, other indications

Certepetide is also rated in:

pancreatic ductal adenocarcinomaDormant
CCC
Indicative ·
51 / 100
View asset →
malignant pancreatic neoplasmDormant
CCC
Indicative ·
51 / 100
View asset →
gallbladder cancerDormant
CCC
Indicative ·
49 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →